Response to Letter about "Chronic spontaneous urticaria after COVID-19 vaccination"
Therapie. 2024 Jan 26:S0040-5957(24)00005-2. doi: 10.1016/j.therap.2024.01.002. Online ahead of print.NO ABSTRACTPMID:38458947 | DOI:10.1016/j.therap.2024.01.002 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Ahmed Zaiem Yasmine Salem Mahjoub Source Type: research
Bariatric surgery and drugs: Review of the literature and Adverse Drug Reactions analysis in French National Pharmacovigilance Database
CONCLUSION: There is a lack of official information and/or recommendations on medication use in subjects who have undergone bariatric surgery. Apart from under-reporting, ADRs reports remain largely uninformative. Health professional and patients would be awareness for improving, quantitatively and qualitatively the reporting of ADRs in this population.PMID:38458944 | DOI:10.1016/j.therap.2024.02.003 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Carole Nicol Julien Jacquot Leila Chebane Sandrine Combret Pauline-Eva Pecquet Nathalie Massy Haleh Bagheri Source Type: research
Medication-overuse headache: A pharmacovigilance study in France
CONCLUSIONS: Certain drug classes show a high reporting rate of MOH and caution should be exercised when prescribing these drugs. Notably, warnings about MOH must be mentioned in the SmPC of all concerned drug classes.PMID:38458945 | DOI:10.1016/j.therap.2024.02.001 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Mohamad Houssam Al Balkhi Julien Moragny Sol ène M Laville Sophie Liabeuf Pauline-Eva Pecquet Benjamin Batteux Cosette Le Souder Florelle Bellet Val érie Gras Kamel Masmoudi Source Type: research
Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France
In conclusion, a number of technical and financial challenges need to be overcome if France is to maintain its position as a European and world leader and increase its contribution to reducing the economic and social burden of rare diseases by developing revolutionary and effective new therapies.PMID:38458946 | DOI:10.1016/j.therap.2024.01.007 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Karyna Lutsyk Tristan Gicquel Lucas Cortial Sylvain Forget Serge Braun Pierre-Olivier Boyer Vincent Laugel Olivier Blin Source Type: research
Response to Letter about "Chronic spontaneous urticaria after COVID-19 vaccination"
Therapie. 2024 Jan 26:S0040-5957(24)00005-2. doi: 10.1016/j.therap.2024.01.002. Online ahead of print.NO ABSTRACTPMID:38458947 | DOI:10.1016/j.therap.2024.01.002 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Ahmed Zaiem Yasmine Salem Mahjoub Source Type: research
Bariatric surgery and drugs: Review of the literature and Adverse Drug Reactions analysis in French National Pharmacovigilance Database
CONCLUSION: There is a lack of official information and/or recommendations on medication use in subjects who have undergone bariatric surgery. Apart from under-reporting, ADRs reports remain largely uninformative. Health professional and patients would be awareness for improving, quantitatively and qualitatively the reporting of ADRs in this population.PMID:38458944 | DOI:10.1016/j.therap.2024.02.003 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Carole Nicol Julien Jacquot Leila Chebane Sandrine Combret Pauline-Eva Pecquet Nathalie Massy Haleh Bagheri Source Type: research
Medication-overuse headache: A pharmacovigilance study in France
CONCLUSIONS: Certain drug classes show a high reporting rate of MOH and caution should be exercised when prescribing these drugs. Notably, warnings about MOH must be mentioned in the SmPC of all concerned drug classes.PMID:38458945 | DOI:10.1016/j.therap.2024.02.001 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Mohamad Houssam Al Balkhi Julien Moragny Sol ène M Laville Sophie Liabeuf Pauline-Eva Pecquet Benjamin Batteux Cosette Le Souder Florelle Bellet Val érie Gras Kamel Masmoudi Source Type: research
Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France
In conclusion, a number of technical and financial challenges need to be overcome if France is to maintain its position as a European and world leader and increase its contribution to reducing the economic and social burden of rare diseases by developing revolutionary and effective new therapies.PMID:38458946 | DOI:10.1016/j.therap.2024.01.007 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Karyna Lutsyk Tristan Gicquel Lucas Cortial Sylvain Forget Serge Braun Pierre-Olivier Boyer Vincent Laugel Olivier Blin Source Type: research
Response to Letter about "Chronic spontaneous urticaria after COVID-19 vaccination"
Therapie. 2024 Jan 26:S0040-5957(24)00005-2. doi: 10.1016/j.therap.2024.01.002. Online ahead of print.NO ABSTRACTPMID:38458947 | DOI:10.1016/j.therap.2024.01.002 (Source: Therapie)
Source: Therapie - March 8, 2024 Category: Psychiatry & Psychology Authors: Ahmed Zaiem Yasmine Salem Mahjoub Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
Methimazole-induced urticaria in hyperthyroid patients: A safe re-administration protocol
CONCLUSION: Given the importance of this drug in the management of hyperthyroidism, MMI should not be withdrawn in cases of urticaria. After the resolution of urticaria, a gradual reintroduction of MMI should be attempted with concomitant antihistamine therapy.PMID:38403562 | DOI:10.1016/j.therap.2023.12.006 (Source: Therapie)
Source: Therapie - February 25, 2024 Category: Psychiatry & Psychology Authors: Ferdaous Chahed Nadia Ben Fredj Haifa Ben Romdhane Zohra Chadli Amel Chaabane Najah Ben Fadhel Karim Aouam Source Type: research
